Through the study of transcriptional activation in response to interferon a (IFN-a) and interferon y (IFN-y), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription). The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription. Recognition of the molecules involved in the IFN-a and IFN-y pathway has led to discoveries that a number of STAT family members exist and that other polypeptide ligands also use the Jak-STAT molecules in signal transduction.
, whereas many genes are activated rapidly and specifically only by particular ESPs (4) (5) (6) (7) (8) (9) (10) . Because cells probably have receptors to many dozens of different ESPs simultaneously, a central question arises: How is the specific transcriptional response to a particular ESP achieved?
Over the past decade, experiments exploring the induction of transcription by IFN-a (5, 7, 8, (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and IFN-y (21) (22) (23) (24) (25) (26) (27) (28) have permitted a general understanding of many individual pathways of signal transduction that connect events at the cell surface directly to gene activation. We refer to these as the Jak-STAT family of pathways; they begin with the binding of ESPs to specific receptors that are associated with protein tyrosine kinases that become activated by ligand attachment. The kinases presently known to function in these pathways belong to the Janus kinase Uak) family (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) , and their activation is associated with their own phosphorylation on tyrosine residues. The Jak proteins, as we will discuss, can be associated with receptors that either possess or lack tyrosine kinase activities of their own. Latent cytoplasmic proteins termed STATs (signal transducers and activators of transcription) (36, (41) (42) (43) also become activated, presumably by the Jaks, through phosphorylation of tyrosine residues. The activated STAT proteins are translocated to the nucleus where, by themselves or in combination with otherwise weak DNA binding proteins, they bind to specific sequences (response elements) and stimulate transcription. These conclusions have been reached by two parallel approaches: biochemistry and gene cloning on the one hand (1 1-28, 36-43) and somatic cell genetics on the other (33) (34) (35) (44) (45) (46) (47) (12, 13, 19, 20 (58) (59) (60) . This family includes IRF-1 and IRF-2 (interferon regulatory factors 1 and 2), which in transfection experiments can be shown to be positive and negative acting proteins, respectively, acting through a DNA element ('TTCNNlFlT) that represents the core but not the entire ISRE (58) (59) (60) . The 48-kD protein also has a weak sequence similarity to the protein encoded by myb (58) (59) (60) (43, 67) . This residue is in the same relative position in the two proteins, and the sequences downstream from the site have four of nine amino acids conserved (Fig. 1) . The sites do not resemble those around phosphotyrosine residues in other proteins.
Binding factor GAF activated by IFN-.y. After the first GAS element in the gene encoding GBP was delineated, a -y-activated factor (GAF) that binds to this element was detected (23, 24) . The protein or proteins required to form GAF preexist in the cytoplasm and are activated rapidly in response to IFN-y without new protein (26, 28) . Although GAF activity is immediately activated in response to IFN-y as is the transcription of some genes, GAF disappears within 2 to 3 hours, whereas IFN--y-induced transcription continues much longer (21, 23, 43 
Conclusion
At this point, a fairly complete picture o the major intracellular molecules involve in the IFN-at and IFN-y signal transductio pathways is available and a model of th pathways can be drawn (Fig. 2 ). An LE binding subunit of each type of LEN recep tor has been cloned and characterized (76 77) , and the cloning of a second subunit o the IFN--y receptor has recently been re ported (78, 79 Fig. 2 .
As with many growth factors and cytokines, the first interaction in the pathway after ligand receptor interaction may be receptor dimerization. The Jak family members are shown associated with the receptors, and as we will point out later, such an arrangement was first strongly suggested because of the association of Jak family members with other receptors. The evidence for the association of Jak family members with IFN receptors is mainly indirect. UlA cells (lacking Tyk2) or U4A cells (lacking Jakl) do not bind IFN-a well (33) . Antiserum against Jakl readily detects this kinase in crude membrane preparations (81) , and Jak2 co-immunoprecipitates with a subunit of the IFN-y receptor (82) . Finally, crude membrane preparations from broken cells can be activated with IFN-ct and IFN-y and produce ISGF-3 or GAF, which implies that there is an association of the kinases with membrane preparations (83, 84) . In accord with the phosphorylation and genetic data, we assume that Jakl and Jak2 are associated with the IFN-^y receptor and that JakI and Tyk2 are associated with the IFN-a receptor. It remains unclear which kinase functions first. Because Jakl is activated by both IFN-a and IFN-y and Statl is phosphorylated after treatment with each ligand, perhaps JakI is the kinase that directly phosphorylates Statl and Tyk2 is the kinase for Stat2. The IFN-y receptor is reported to be phosphorylated on tyrosine in response to IFN-y, and Statl may bind to this receptor only after phosphorylation (85). Whatever the case, a macromolecular assembly including (at least) two chains of the receptor plus two associated kinase molecules is proposed to form a multiprotein complex to which a STAT family member is bound, probably by its SH2 domain (36) . It is also possible that such complexes could contain one of the many cytoplasmic phosphotyrosine phosphatases that have been described (86) . We suggest that after IFN-y treatment and activation of the multiprotein IFN-y receptor-kinase complex, only Statla binds and becomes phosphorylated; dimeric phosphorylated Statl then enters the nucleus and, through binding to GAS elements (perhaps in association with other nuclear proteins), activates IFN-y-dependent transcription. After IFN-cx treatment, a receptor complex with phosphorylated Jakl and Tyk2 allows recognition and phosphorylation of both Stat2 and Statl. Phosphorylation of Statl could lead to transient activation of some genes by both IFN-a and IFN--y, but because GAF activation is transient the more potent and long-lasting activation of genes by IFN-at requires action through an ISRE. The long-lasting activation of transcription after IFN-y treatment (14, 19, 21) presumably requires some secondary response because GAF activation is transient (42, 87) .
Jak and STAT proteins in other ESPactivated pathways. Do the Jak and STAT proteins described here or similar proteins function in gene activation after other polypeptides attach to their specific receptors? Many receptors for different cytokines and growth factors (ESPs) are well defined, but in comparison with the IFNs less is known concerning the affected transcription factors or even whether different ligand-specific response elements are used to activate concerted groups of genes. However, recent evidence demonstrates that ligand-receptor interactions other than those with the IFNs can activate the Jak-STAT proteins already known, and several other STAT proteins have now been discovered. Thus, the generality of the Jak-STAT pathways in polypeptide-induced transcription seems likely (88-93). For example, the binding site in DNA that controls the transcription of the interleukin-6 (IL-6)-responsive genes and the serum-induced element (SIE) of c-fos (especially in its mutated, hyperactive form) can direct activation of plasmid transcription by IL-6 or epidermal growth factor (EGF), respectively, and both these sites resemble the GAS site defined for IFN--y (88, 94). Treatment of cells with IL-6, EGF, or platelet-derived growth factor leads to tyrosine phosphorylation of Statl or related proteins and the binding of these proteins to the SIE, GAS, and IL-6 sites (88-93). The bandshift complexes induced by IFN-y, EGF, or IL-6 are not identical, however, and proteins in extracts of different treated cells bind with different affinities to the SIE, GAS, or IL-6 sites. Three bandshift complexes (termed SIFA, SIFB, and SIFC) are produced with the SIE after treatment of epithelial cells with EGF. The slowest of these comigrates with the major IL-6-induced complex from hepatoma cells (88, 89). Proteins in the fastest migrating and the middle complexes (SIFC and SIFB, respectively) react with antiserum to Stat1, but those in the slowest migrating band (SIFA) do not. Antibodies to another STAT family member, termed Stat3, show that it is phosphorylated in response to either EGF or IL-6 and that the antibodies react with the middle and top band induced by EGF and the major band induced by (63 (66) , has about 25% amino acid identity with other family members. These results indicate that the STAT family will provide the cell with a set of proteins that allow a flexible response to different ligands.
A crucial unanswered question is how many clearly distinct response elements exist. Although the IFN-a response element, the ISRE, is clearly different from the IFN--y element, GAS, the EGF, IL-6, and prolactin elements are all similar to the GAS site. Perhaps the variation around the GAS core sequence will be important in determining specificity for these various factors. The solution to this problem is to find more genes for which transcription is immediately activated by the binding of particular polypeptides and then to characterize the required DNA binding sites and the proteins that bind them.
The finding that proteins other than the IFNs can lead to STAT phosphorylation and activation as DNA binding proteins is paralleled by studies broadening the range of receptors associated with the Jak family. Jak2 or a closely related protein coprecipitates with the erythropoietin receptor, and there is also evidence that Jak2 or a close relative is attached to the growth hormone and IL-3 receptors (38, 39) . Tyrosine phosphorylation of Jak proteins has been demonstrated in response to such polypeptides as growth hormone, leukemia inhibitory factor, ciliary neurotrophic factor, IL-3, and erythropoietin (38-40, 88, 89 (Fig. 3) . In the pathway, there are four steps where specificity seems to be required for different protein ligands to have different effects on cells.
1) The ligand-receptor interaction is widely acknowledged to be specific.
2) The receptor-kinase complex could also be specific and can obviously involve transmembrane tyrosine kinases like the EGF receptor as well as receptors with no intrinsic kinase activity. Other "soluble" kinases (as the Jaks were formerly regarded) could also be involved. Most if not all 
